Metformin Weight Loss: Evidence, Label Rules, and Risks
Medically reviewed by Medical Advisory Board Last reviewed 2026-05-13
Metformin is approved for type 2 diabetes rather than weight management with no quantified weight loss figure published by clinical reference sources
Metformin is not approved for weight loss; its approved use is type 2 diabetes. The sources we cite give no expected pounds lost. The Diabetes Prevention Program tracked diabetes onset, and any decision to take the drug sits with your prescriber.
Metformin is approved to treat type 2 diabetes. It has no approval for weight loss, and primary clinical references do not publish a weight loss figure for people taking it. At The Metabolic Journal, we examine clinical drug records to help you evaluate metabolic therapies alongside your physician. Some people see weight changes on it. It still lacks approval as a weight-management therapy.
Prescription guidance from MedlinePlus documents metformin for type 2 diabetes, alone or with other medications. The Diabetes Prevention Program (DPP) is described by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Weighing it means checking approved uses, trial endpoints, side effects, and administration rules.
Partner · Opt Health
Want medical weight loss instead of another diet?
Opt Health prescribes and monitors GLP-1 therapy against real labs — insulin, A1C, lipids, thyroid, hormones — so the plan fits your physiology rather than a generic protocol. Medication ships to your door.
See Opt Health's weight-loss program →Does Metformin Help with Weight Loss?
Metformin does not have regulatory approval for weight loss, and primary medical sources do not state a specific weight-loss amount for patients who take it. MedlinePlus states that metformin is prescribed alone or with other medications, including insulin, to treat type 2 diabetes. While some people lose weight during treatment, authoritative reference sources do not provide an expected pound or percentage reduction figure.
Many patients ask whether metformin helps you lose weight. If your primary goal is body weight reduction, you can compare different options in our reviews of Ozempic vs metformin and Zepbound vs metformin.
What Metformin Does in the Body
Metformin alters how the body manages blood sugar through three distinct mechanisms documented by MedlinePlus. It decreases the amount of glucose you absorb from food. It decreases the amount of glucose made by the liver. It also increases the body's response to insulin.
| Biological action | Documented effect | Clinical outcome |
|---|---|---|
| Glucose absorption | Decreases glucose absorbed from food | Less glucose taken in from food |
| Liver glucose production | Decreases glucose made by the liver | Less glucose made by the liver |
| Insulin sensitivity | Increases the body's response to insulin | A stronger response to insulin |
For background on how the body responds to insulin, see our pages on insulin resistance and how to reverse insulin resistance.
Diabetes Prevention Program Evidence on Metformin Weight Loss
The Diabetes Prevention Program demonstrated that metformin reduces the risk of developing type 2 diabetes, but the trial evaluated diabetes incidence rather than weight loss. The NIDDK reports that participants in the lifestyle intervention group had a goal to lose 7 percent of body weight. Over the initial study period, that lifestyle program lowered the chances of developing type 2 diabetes by 58 percent compared to placebo. Metformin lowered the chances of developing type 2 diabetes by 31 percent compared to placebo over that same initial period. Participants assigned to the medication arm took 850 mg of metformin twice a day.
Long-term follow-up tracking published by the NIDDK showed continued differences in diabetes delay over extended periods:
- At the 10-year follow-up: The lifestyle intervention delayed diabetes onset by 34 percent while metformin delayed diabetes onset by 18 percent.
- At the 15-year follow-up: The lifestyle intervention delayed diabetes onset by 27 percent while metformin delayed diabetes onset by 18 percent.
- Cumulative diabetes incidence: In total, 55 percent of participants in the lifestyle group, 56 percent in the metformin group, and 62 percent in the placebo group had developed diabetes.
The NIDDK noted that metformin was most effective in women with a history of gestational diabetes, in people aged 25 to 44, and in people with obesity and a body mass index (BMI) of 35 or higher. The primary trial outcome was diabetes prevention. The NIDDK page does not state how much weight the metformin group lost.
| DPP study arm | Initial risk reduction vs placebo | 10-year diabetes delay | 15-year diabetes delay | Cumulative diabetes rate |
|---|---|---|---|---|
| Lifestyle program | 58 percent lower | 34 percent delayed | 27 percent delayed | 55 percent |
| Metformin (850 mg twice daily) | 31 percent lower | 18 percent delayed | 18 percent delayed | 56 percent |
| Placebo group | Reference baseline | Reference baseline | Reference baseline | 62 percent |
Side Effects, Safety Warnings, and Formulations
MedlinePlus lists common side effects and a warning about lactic acidosis. MedlinePlus lists the most common side effects as diarrhea, nausea, stomach discomfort, gas, indigestion, constipation, and lack of energy or weakness.
A rare but serious and life-threatening condition associated with metformin is lactic acidosis. The risk of developing lactic acidosis is higher in people with kidney disease, people over age 65, people with heart or liver disease, and individuals taking certain medications, specifically acetazolamide, topiramate, or zonisamide. Warning symptoms of lactic acidosis include extreme tiredness, weakness, nausea, vomiting, stomach pain, deep and rapid breathing, dizziness, and muscle pain.
| Category | Documented details | Action required |
|---|---|---|
| Common side effects | Diarrhea, nausea, stomach discomfort, gas, indigestion, constipation, weakness | Listed by MedlinePlus as common |
| Lactic acidosis symptoms | Extreme tiredness, weakness, nausea, vomiting, stomach pain, rapid breathing, dizziness, muscle pain | Warning symptoms listed by MedlinePlus |
| Higher-risk groups | Kidney disease, age over 65, heart disease, liver disease, acetazolamide, topiramate, zonisamide | Higher risk of lactic acidosis, per MedlinePlus |
| Procedure safety | X-ray procedures that use dye | Metformin is stopped beforehand; restarted no sooner than 48 hours afterward |
| Nutritional monitoring | Low vitamin B12 levels | MedlinePlus says to tell your doctor |
MedlinePlus states that patients should avoid metformin if they have kidney disease. In addition, you must tell your doctor if you have or have had low vitamin B12 levels. If you need an x-ray procedure that uses dye, metformin is stopped beforehand, and treatment is restarted no sooner than 48 hours afterward.
Metformin is available in three distinct formulations: standard tablets, extended-release tablets, and liquid. Extended-release tablets are taken once daily. You must swallow extended-release tablets whole, and do not split, chew, or crush them.
Patient Safety Exclusions and Metformin Weight Loss Decisions
Metformin should be avoided by individuals with kidney disease and it is not approved for weight loss. Someone without type 2 diabetes who is searching for a weight-reduction medication should speak with their physician about options.
An official regulatory indication approving metformin for weight management or new published data from official health agencies quantifying its weight loss outcomes would change our answer. Today the cited sources give no weight loss figure at all.
For patients exploring alternatives for blood sugar management or insulin sensitivity, our clinical comparisons review metformin alternatives and berberine vs metformin. If your physician is considering combination approaches for metabolic regulation, review our guide on taking metformin and Zepbound together. Talk with your doctor about your labs and history before weighing metformin for weight loss.
What to Look For in a Body-Composition Scale
A bioimpedance scale trends body fat and muscle rather than just weight — useful when the number stalls but your composition is improving. The absolute body-fat % isn't lab-accurate, so use it for TRENDS at a consistent time of day. Choose one that syncs to an app so you can watch the trend line.
Frequently Asked Questions
Does metformin help with weight loss?
Metformin is not approved for weight loss, and primary medical sources do not publish a quantified weight loss figure for people taking it. Some individuals experience weight changes during treatment for type 2 diabetes, but clinical trials such as the Diabetes Prevention Program evaluated diabetes incidence rather than weight loss. Consult your physician to discuss approved treatments for weight management.
Is metformin approved for weight loss?
No, metformin is not approved for weight loss. According to MedlinePlus, metformin is approved alone or with other medications, including insulin, to treat type 2 diabetes.
What are the side effects of metformin?
Common side effects of metformin include diarrhea, nausea, stomach discomfort, gas, indigestion, constipation, and lack of energy or weakness. Metformin also carries a risk of lactic acidosis, a rare but life-threatening condition. Warning symptoms of lactic acidosis include extreme tiredness, weakness, nausea, vomiting, stomach pain, deep and rapid breathing, dizziness, and muscle pain.
What did the Diabetes Prevention Program find about metformin?
The Diabetes Prevention Program found that taking 850 mg of metformin twice daily lowered the chances of developing type 2 diabetes by 31 percent compared to placebo over the initial study period. In comparison, a lifestyle intervention program aimed at losing 7 percent of body weight reduced the chances by 58 percent. At 10-year follow-up, metformin delayed diabetes by 18 percent, and at 15-year follow-up, it delayed diabetes by 18 percent. The trial evaluated diabetes prevention, and the NIDDK page does not state how much weight the metformin group lost.
Who should not take metformin?
Metformin should be avoided by people with kidney disease. The risk of developing serious lactic acidosis is also higher in people over age 65, people with heart or liver disease, and individuals taking acetazolamide, topiramate, or zonisamide. Patients must tell their doctor if they have low vitamin B12 levels, and metformin is stopped before x-ray procedures that use dye.
Topic updates
Get the weekly metabolic health roundup
Insulin resistance, blood sugar, visceral fat, GLP-1 plateaus, metabolic syndrome, and weight-loss physiology.
Want weight loss handled by a physician who works from your labs? See how Opt Health does it →
Check Where You Stand
Take our free health assessment to understand your metabolic, hormonal, and recovery risk factors — and get personalized recommendations.
Take the Free Assessment →Free · Takes 5 minutes · Instant results
Related Guides
-
Ozempic and GLP-1 for Weight Loss: Results, Timelines, and What to Expect
Ozempic results, timelines, side effects, and what to do when it stops working.
-
How to Get Prescribed Ozempic for Weight Loss: Eligibility, Costs, and Safer Next Steps
Prescription eligibility, insurance friction, and safer metabolic next steps for Ozempic weight-loss seekers.
-
Mounjaro Weight Loss
Mounjaro (tirzepatide) for weight loss: mechanism, dose titration, expectations, and side effects.
See more related guides
-
Topiramate Weight Loss
Topiramate for weight loss: the Qsymia (phentermine-topiramate) combination, evidence vs GLP-1 drugs, and the pregnancy warning.
-
Evidence-based Weight Loss Tips: What Actually Works, Ranked
Non-drug weight loss fundamentals ranked by evidence strength, from diet quality to sleep to hormone stalls.
-
Does Bulletproof Coffee Help Weight Loss
Whether butter/MCT coffee actually helps weight loss: the satiety and ketosis mechanisms vs. the calorie math.
-
L-glutamine and Weight Loss
Whether L-glutamine causes weight loss: the athlete meta-analysis, the AIDS-wasting trials, and why a moving scale isn't the same as fat loss.
-
Is Oatmeal Good for Weight Loss? the Beta-glucan Trial Evidence
Is oatmeal good for weight loss? The beta-glucan mechanism, the trial evidence, and how prep method changes the effect.
Affiliate disclosure: The Metabolic Journal is reader-supported. Some links above are affiliate or referral links and we may earn a commission at no extra cost to you. As an Amazon Associate we earn from qualifying purchases. Products are chosen on the merits; commissions never influence what we recommend. This is general information, not medical advice — talk to your clinician before acting.